Sort
82,697 grants matching “vaccine development”
Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides
$800,715Scott G Hansen · Oregon Health & Science University · R01 · FY2018 · AI
A Multidisciplinary Approach to Understanding TB Latency and Reactivation
$800,674Petros C Karakousis · Johns Hopkins University · R01 · FY2010 · HL
Neonatal Immunity to novel TF SHIVs
$800,666Wilton B Williams · Duke University · R37 · FY2025 · AI
Malaria Pathogenesis in young children and vaccine discovery
$800,611Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
$800,605Pia S Pannaraj · Children'S Hospital Of Los Angeles · R01 · FY2022 · AI
Optimizing protective vaccine targets in the V1/V2 domain of HIV-1 gp120
$800,581Abraham Pinter · Rbhs-New Jersey Medical School · R01 · FY2014 · AI
Exploiting the antigenic conservation of the Env trimer apex across primate lentiviral lineages for AIDS vaccine design
$800,558Beatrice H Hahn · University Of Pennsylvania · R01 · FY2020 · AI
Exploiting the antigenic conservation of the Env trimer apex across primate lentiviral lineages for AIDS vaccine design
$800,558Beatrice H Hahn · University Of Pennsylvania · R01 · FY2019 · AI
The NEPRC SPF Rhesus Macaque Breeding Colony
$800,529Lynn Wachtman · Harvard Medical School · U42 · FY2012 · OD
Understanding RTS,S malaria vaccine-induced protection through integrated analysi
$800,522Carlota Dobano · Barcelona International Health Res Ctr · R01 · FY2014 · AI
Examining biomarkers and mechanisms of health disparities in sexual minority women
$800,522Kathryn Elizabeth Keenan · University Of Chicago · R01 · FY2017 · HL
Protective Human Monoclonal Antibodies to HIV-1
$800,505Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2010 · HL
Understanding Unconventional CD8+ T cell Responses in Protection from HIV
$800,450Jonah B. Sacha · Oregon Health & Science University · R01 · FY2021 · AI
A Multicomponent Anthrax Vaccine using Phage T4 Display
$800,395Venigalla B. Rao · Catholic University Of America · U01 · FY2007 · AI
Assembly of MHC Class I Molecules in Vitro and in Vivo
$800,339Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2010 · AI
Exploratory Human Trials of Combination Rectal Microbicides
$800,327Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2013 · AI
Accelerating malaria prevention through enhanced analysis of transmission and RTS,S vaccination in Malawi
$800,270Don P Mathanga · Kamuzu University Of Health Sciences · U19 · FY2024 · AI
Protective Human Monoclonal Antibodies to HIV-1
$800,269Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2012 · HL
Mechanisms of IFNg-independent T cell and B cell-mediated protection in TB.
$800,200Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
RNA Metabolism in Trypanosomes
$800,174Christian Tschudi · Yale University · R01 · FY2017 · AI
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
$800,168Anne Moscona · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$800,161Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2015 · AI
Native American Research Centers For Health (NARCH XII)
$800,123Daniel J. Calac · Indian Health Council, Inc. · S06 · FY2023 · GM
Model Development, Data Analysis, and Simulation for Affinity Maturation
$800,116Thomas B Kepler · Boston University Medical Campus · U19 · FY2017 · AI
Regulatory T cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$800,066Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AI